胃内容物中甲卡西酮LC-MS/MS检验方法研究

目的:建立胃内容物中甲卡西酮及其代谢物卡西酮的LC-MS/MS检验方法。方法:以双苯戊二氨酯(SKF525A)为内标,Column Eclipse Plus C18色谱柱(1.8μm, 100 mm×3 mm)为固定相,流动相为0.1%甲酸水溶液和乙腈,梯度洗脱,流速为0.3m L/min,进样量为1μL。通过电喷雾离子源(ESI),利用正离子多反应监测模式(MRM)进行检测。结果:胃内容物中甲卡西酮检验方法线性范围为1-5000 ng/g,标准曲线方程Y=0.026X+0.4501(R2=0.9998),检出限为0.5 ng/g,定量限为1.0 ng/g;卡西酮的检验方法线性范围为2-5000 ng/g,标准曲线方程Y=0.0099X+0.1576(R2=0.9997),检出限为1.0 ng/g,定量限为2.0 ng/g。结论:该方法操作简便,检测灵敏度较高,可用于甲卡西酮中毒案件胃内容物中甲卡西酮及其代谢物卡西酮的检验。     

Synthetic cathinones: Chemical phylogeny,physiology, and neuropharmacology

This mini-review summarizes the history of cathinone and its synthesized derivatives from early records to the present day, including the appearance of synthetic cathinones in the drug combination known as bath salts. Bath salts may consist of one compound (MDPV) or combinations of MDPV and one or more other synthetic cathinones, which may also appear alone without MDPV. We briefly review recent in vitro studies of bath salts components alone or in combination, focusing on pharmacological and biophysical studies. Finally we summarize new data from in vivo procedures that characterize the abuse-related neurochemical and behavioral effects of synthetic cathinones in rats.     

Urine as a material for evaluation of exposure to manganese in methcathinone users

Chronic exposure even to low doses of manganese may lead to development of neurological syndrome similar to parkinsonism. The aim of this research is to assess the possibility of manganese poisoning based on the level of metal in the urine of long-term methcathinone users from Poland. Graphite furnace atomic absorption spectroscopy (GFAAS) was used to determine manganese in urine, while the detection of the psychoactive drugs was performed by high-performance liquid chromatography (HPLC). Results of survey on longitudinal patterns of drug use showed that users of traditional illicit drugs now turn to cheaper alternatives, such as methcathinone. Parkinsonian features were observed in almost half of methcathinone users. The subjects had a higher mean level of Mn in their urine (8.68 ± 9.27 μg L⁻¹) than the controls (4.27 ± 1.91 μg L⁻¹). The presence of numerous psychoactive substances (in unchanged forms and their metabolites) was confirmed in all of the samples, with only one exception. The elevated level of manganese in urine (in 29.2% of patients) can be used as a primary marker of recent methcathinone administration, especially in the case of long time intravenous drug users where blood sampling is complicated.